Regeneron Pharmaceuticals | REGN - Dochód Netto





Dochód Netto Zmiana Data
AbbVie USD 695M 1.12B 2026-03
Agenus USD -10.63M 74.49M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Astellas Pharma JPY 43.52B 56.86B 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
J&J USD 5.24B 119M 2026-03
Kyowa Hakko Kirin JPY 12.03B 22.41B 2026-03
Merck USD -4.24B 7.2B 2026-03
Moderna USD -1.34B 517M 2026-03
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Teva Pharmaceutical Industries USD 369M 111M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
United Therapeutics USD 274.9M 89.4M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03